Start HPV shots at age 9? new study aims to save lives
NCT ID NCT04722822
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study tests if giving the HPV vaccine to children at age 9-10, instead of the usual 11-12, leads to more kids getting fully vaccinated before they are exposed to the virus. The goal is to prevent HPV-related cancers later in life. About 3,100 children in Colorado and California are taking part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California at Los Angeles
Los Angeles, California, 90095, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simple blood test could spot returning throat cancer sooner
- Double probe heat therapy may slash cervical cancer risk in HIV-positive women
- New probe technique could slash cervical cancer risk in HIV-Positive women
- New digital platform aims to boost HPV vaccine confidence in schools
- Web lessons aim to bust HPV test fears
- HPV vaccine pilot shows promise for High-Risk groups